✨ New Medicines Consent
5654 NEW ZEALAND GAZETTE, No. 193 15 DECEMBER 2011
Product: Latisse
Active Ingredient: Bimatoprost 0.3mg/mL
Dosage Form: Topical solution
New Zealand Sponsor: Allergan New Zealand Limited
Manufacturer: Allergan Sales LLC, Texas, United States of America
Product: Lax-Sachets
Active Ingredients:
- Macrogol 3350 13.125g
- Potassium chloride 46.6mg
- Sodium bicarbonate 178.5mg
- Sodium chloride 350.7mg
Dosage Form: Powder for oral solution
New Zealand Sponsor: AFT Pharmaceuticals Limited
Manufacturer: Strides Arcolab Limited, Bangalore, India
Product: Lax-Sachets Half
Active Ingredients:
- Macrogol 3350 6.563g
- Potassium chloride 23.3mg
- Sodium bicarbonate 89.25mg
- Sodium chloride 175.35mg
Dosage Form: Powder for oral solution
New Zealand Sponsor: AFT Pharmaceuticals Limited
Manufacturer: Strides Arcolab Limited, Bangalore, India
Product: Lo-Oralcon 20
Active Ingredients:
- Ethinylestradiol 0.02mg
- Levonorgestrel 0.1mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Arrow Pharmaceuticals (NZ) Limited
Manufacturer: Famy Care Limited, Gujarat, India
Product: Lo-Oralcon 20 ED
Active Ingredients:
- Ethinylestradiol 0.02mg
- Levonorgestrel 0.1mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Arrow Pharmaceuticals (NZ) Limited
Manufacturer: Famy Care Limited, Gujarat, India
Product: Nicorette® QuickMist Mouth Spray
Active Ingredient: Nicotine tartrate 13.6mg/mL
Dosage Form: Oral spray
New Zealand Sponsor: Johnson & Johnson (New Zealand) Limited
Manufacturer: McNeil AB, Helsingborg, Sweden
Product: Oseltamivir
Active Ingredient: Oseltamivir phosphate 98.5mg
Dosage Form: Capsule
New Zealand Sponsor: REX Medical Limited
Manufacturer: Cipla Limited, Goa, India
Product: Your Pharmacy Cough, Cold & Flu PE
Active Ingredients:
- Guaifenesin 100mg
- Paracetamol 500mg
- Phenylephrine hydrochloride 6.1mg equivalent to phenelphrine 5mg
Dosage Form: Capsule
New Zealand Sponsor: Orion Laboratories (NZ) Limited
Manufacturer: Wrafton Laboratories Limited, Devon, United Kingdom
Dated this 7th day of December 2011.
DR DON MACKIE, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
Next Page →
✨ LLM interpretation of page content
🏥
Consent to the Distribution of New Medicines
(continued from previous page)
🏥 Health & Social Welfare7 December 2011
Medicines Act 1981, New Medicines, Latisse, Lax-Sachets, Lax-Sachets Half, Lo-Oralcon 20, Lo-Oralcon 20 ED, Nicorette® QuickMist Mouth Spray, Oseltamivir, Your Pharmacy Cough, Cold & Flu PE
- DR DON MACKIE, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health
NZ Gazette 2011, No 193